4.7 Article

Functional Synergy between Antimicrobial Peptoids and Peptides against Gram-Negative Bacteria

Journal

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 55, Issue 11, Pages 5399-5402

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.00578-11

Keywords

-

Funding

  1. Department of Homeland Security
  2. NIH [1R01 HL67984, 1R01 AI072666]

Ask authors/readers for more resources

Antimicrobial peptides (AMPs) are integral components of innate immunity and are typically found in combinations in which they can synergize for broader-spectrum or more potent activity. Previously, we reported peptoid mimics of AMPs with potent and selective antimicrobial activity. Using checkerboard assays, we demonstrate that peptoids and AMPs can interact synergistically, with fractional inhibitory concentration indices as low as 0.16. These results strongly suggest that antimicrobial peptoids and peptides are functionally and mechanistically analogous.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Clinical Neurology

Targeting Infectious Agents as a Therapeutic Strategy in Alzheimer's Disease

Tamas Fulop, Usma Munawara, Anis Larbi, Mathieu Desroches, Serafim Rodrigues, Michele Catanzaro, Andrea Guidolin, Abdelouahed Khalil, Francois Bernier, Annelise E. Barron, Katsuiku Hirokawa, Pascale B. Beauregard, David Dumoulin, Jean-Philippe Bellenger, Jacek M. Witkowski, Eric Frost

CNS DRUGS (2020)

Article Chemistry, Medicinal

Potent Antiviral Activity against HSV-1 and SARS-CoV-2 by Antimicrobial Peptoids

Gill Diamond, Natalia Molchanova, Claudine Herlan, John A. Fortkort, Jennifer S. Lin, Erika Figgins, Nathen Bopp, Lisa K. Ryan, Donghoon Chung, Robert Scott Adcock, Michael Sherman, Annelise E. Barron

Summary: Antimicrobial peptides (AMPs) have shown potential as novel antiviral drugs by inactivating viruses through disrupting their envelopes. However, their clinical development has been hindered by their enzymatically labile structure. Peptoid mimics of AMPs have been investigated for their potent in vitro antiviral activity against HSV-1 and SARS-CoV-2, with potential as safe and effective broad-spectrum antiviral agents due to their stability and bioavailability.

PHARMACEUTICALS (2021)

Article Geriatrics & Gerontology

Hyperactivation of monocytes and macrophages in MCI patients contributes to the progression of Alzheimer's disease

Usma Munawara, Michael Catanzaro, Weili Xu, Crystal Tan, Katsuiku Hirokawa, Nabil Bosco, David Dumoulin, Abdelouahed Khalil, Anis Larbi, Simon Levesque, Charles Ramassamy, Annelise E. Barron, Stephen Cunnane, Pascale B. Beauregard, Jean-Pierre Bellenger, Serafim Rodrigues, Mathieu Desroches, Jacek M. Witkowski, Benoit Laurent, Eric H. Frost, Tamas Fulop

Summary: The study found distinct phenotypic and functional changes in monocyte and macrophage populations as the disease progresses. Higher free radical production was observed in the monocytes of SMC patients, while the strongest activation of peripheral monocytes was seen in the MCI group. Monocytes exhibited increased chemotaxis, free radical production, and cytokine production in response to TLR2 and TLR4 stimulation, suggesting activation of the peripheral innate immune system during disease progression.

IMMUNITY & AGEING (2021)

Article Chemistry, Medicinal

Self-Assembly of Antimicrobial Peptoids Impacts Their Biological Effects on ESKAPE Bacterial Pathogens

Josefine Eilso Nielsen, Morgan Ashley Alford, Deborah Bow Yue Yung, Natalia Molchanova, John A. Fortkort, Jennifer S. Lin, Gill Diamond, Robert E. W. Hancock, Havard Jenssen, Daniel Pletzer, Reidar Lund, Annelise E. Barron

Summary: Antimicrobial peptides (AMPs) show promise as pharmaceutical candidates for preventing and treating infections caused by multidrug-resistant pathogens. Peptoids, designed as AMP mimics, exhibit antibacterial activity through self-assembly, with different morphologies affecting efficacy.

ACS INFECTIOUS DISEASES (2022)

Article Multidisciplinary Sciences

Broad-spectrum CRISPR-mediated inhibition of SARS-CoV-2 variants and endemic coronaviruses in vitro

Leiping Zeng, Yanxia Liu, Xammy Huu Nguyenla, Timothy R. Abbott, Mengting Han, Yanyu Zhu, Augustine Chemparathy, Xueqiu Lin, Xinyi Chen, Haifeng Wang, Draven A. Rane, Jordan M. Spatz, Saket Jain, Arjun Rustagi, Benjamin Pinsky, Adrianna E. Zepeda, Anastasia P. Kadina, John A. Walker, Kevin Holden, Nigel Temperton, Jennifer R. Cochran, Annelise E. Barron, Michael D. Connolly, Catherine A. Blish, David B. Lewis, Sarah A. Stanley, Marie F. La Russa, Lei S. Qi

Summary: The authors demonstrate that CRISPR-Cas13d can effectively inhibit a wide range of human coronaviruses, including new SARS-CoV-2 variants, in combination with small molecule drugs. The CRISPR-Cas13d system reduces viral titers by over 99% and enhances the therapeutic effects of different antiviral drugs. Lipid nanoparticle-mediated RNA delivery enables the Cas13d system to treat infections from multiple coronavirus variants in human primary airway epithelium cultures. This study establishes CRISPR-Cas13 as a broad-spectrum antiviral strategy that complements existing vaccination and antiviral treatment strategies.

NATURE COMMUNICATIONS (2022)

Article Immunology

Upregulating Human Cathelicidin Antimicrobial Peptide LL-37 Expression May Prevent Severe COVID-19 Inflammatory Responses and Reduce Microthrombosis

Karim M. Aloul, Josefine Eilso Nielsen, Erwin B. Defensor, Jennifer S. Lin, John A. Fortkort, Mehrdad Shamloo, Jeffrey D. Cirillo, Adrian F. Gombart, Annelise E. Barron

Summary: COVID-19 is characterized by an intense inflammatory response, and this paper reviews the relevance of the human cathelicidin LL-37 in SARS-CoV-2 infections. LL-37 is an immunomodulatory peptide with direct anti-SARS-CoV-2 activity and pleiotropic effects on inflammation, vascularization, Lewy body formation, and pancreatic islet cell function. Upregulation of LL-37 might be beneficial in reducing the prevalence of severe COVID-19.

FRONTIERS IN IMMUNOLOGY (2022)

Article Microbiology

Efficacy of Cathelicidin-Mimetic Antimicrobial Peptoids against Staphylococcus aureus

Aaron B. Benjamin, Madeleine G. Moule, Maruti K. Didwania, Jonathan Hardy, Panatda Saenkham-Huntsinger, Preeti Sule, Josefine Eilso Nielsen, Jennifer S. Lin, Christopher H. Contag, Annelise E. Barron, Jeffrey D. Cirillo

Summary: Staphylococcus aureus resistance is a major concern in healthcare, and antimicrobial peptoids show promise as an alternative to conventional antibiotics for treating S. aureus wound infections, with efficient killing of bacteria and prevention of biofilm formation and detachment.

MICROBIOLOGY SPECTRUM (2022)

Article Chemistry, Multidisciplinary

Peptoid-Loaded Microgels Self-Defensively Inhibit Staphylococcal Colonization of Titanium in a Model of Operating-Room Contamination

Wenhan Zhao, Haoyu Wang, Xixi Xiao, Lauren De Stefano, Jordan Katz, Jennifer S. Lin, Annelise E. Barron, Thomas P. Schaer, Hongjun Wang, Matthew Libera

Summary: This study investigates the contamination of implantable medical devices by bacteria in the atmosphere of an operating room. The researchers successfully modify titanium surfaces with antimicrobial polymers, which significantly enhance the resistance of the devices to bacterial contamination.

ADVANCED MATERIALS INTERFACES (2022)

Article Chemistry, Medicinal

Anti-persister and Anti-biofilm Activity of Self-Assembled Antimicrobial Peptoid Ellipsoidal Micelles

Jennifer S. Lin, Laurent A. Bekale, Natalia Molchanova, Josefine Eilso Nielsen, Megan Wright, Brian Bacacao, Gill Diamond, Havard Jenssen, Peter L. Santa Maria, Annelise E. Barron

Summary: This study aims to explore a new class of anti-persister drugs called peptoids and demonstrates that a specific antimicrobial peptoid can effectively eliminate persister cells and biofilms, as well as inhibit cytokine production induced by lipopolysaccharides.

ACS INFECTIOUS DISEASES (2022)

Article Biochemistry & Molecular Biology

Membrane-acting biomimetic peptoids against visceral leishmaniasis

Vivek Kumar, Jennifer S. Lin, Natalia Molchanova, John A. Fortkort, Carolin Reckmann, Stefan Braese, Havard Jenssen, Annelise E. Barron, Archana Chugh

Summary: Visceral leishmaniasis (VL) is a neglected tropical disease and the use of cell-permeating peptides as potential drug candidates to treat VL is limited due to their limited biological stability. In this study, peptoids, which are peptide mimics with good biostability, were tested against Leishmania donovani. The addition of N-alkyl hydrophobic chains and bromination yielded compounds with good antileishmanial activity against both intracellular amastigotes and promastigotes, indicating the potential of these peptoids as drug candidates for VL.

FEBS OPEN BIO (2023)

Article Neurosciences

The anti-inflammatory effects of photobiomodulation are mediated by cytokines: Evidence from a mouse model of inflammation

Shirin Shamloo, Erwin Defensor, Peter Ciari, Gaku Ogawa, Laura Vidano, Jennifer S. Lin, John A. Fortkort, Mehrdad Shamloo, Annelise E. Barron

Summary: Photobiomodulation (PBM) is a safe therapeutic approach using specific wavelengths of light to prevent or limit neuroinflammatory processes and neuronal degeneration. In a study on mice, PBM was found to have anti-inflammatory effects by downregulating proinflammatory cytokines and upregulating anti-inflammatory cytokines, resulting in reducing LPS-induced peripheral and central inflammation. This study demonstrates the potential of PBM as an effective anti-inflammatory treatment.

FRONTIERS IN NEUROSCIENCE (2023)

Article Chemistry, Multidisciplinary

Real-Time Monitoring of Multitarget Antimicrobial Mechanisms of Peptoids Using Label-Free Imaging with Optical Diffraction Tomography

Minsang Kim, Yeongmi Cheon, Dongmin Shin, Jieun Choi, Josefine Eilso Nielsen, Myeong Seon Jeong, Ho Yeon Nam, Sung-Hak Kim, Reidar Lund, Havard Jenssen, Annelise E. Barron, Seongsoo Lee, Jiwon Seo

Summary: Antimicrobial peptides (AMPs) are effective against multidrug-resistant bacteria, and peptoids with N-substituted glycine backbone have also shown promise as antimicrobials. This study investigates the structure-activity relationship (SAR) of a library of peptoids and demonstrates that both membrane disruption and intracellular biomass flocculation are important mechanisms of bacterial killing.

ADVANCED SCIENCE (2023)

Article Chemistry, Medicinal

Peptidomimetic Oligomers Targeting Membrane Phosphatidylserine Exhibit Broad Antiviral Activity

Patrick M. Tate, Vincent Mastrodomenico, Christina Cunha, Joshua McClure, Annelise E. Barron, Gill Diamond, Bryan C. Mounce, Kent Kirshenbaum

Summary: The development of durable new antiviral therapies is challenging due to rapid virus evolution and resistance. Peptoids, a family of AMP mimetics, show direct antiviral activity against enveloped viruses by disrupting viral membrane constituents. These findings suggest that peptoids have the potential to be a new family of therapeutics capable of preventing resistance.

ACS INFECTIOUS DISEASES (2023)

Meeting Abstract Biochemistry & Molecular Biology

Monitoring multi-target mechanism of antimicrobial peptoids using real-time and label-free imaging with optical diffraction tomography

Minsang Kim, Yeongmi Cheon, Dongmin Shin, Jieun Choi, Josefine Eilso Nielsen, Myeong Seon Jeong, Reidar Lund, Havard Jenssen, Annelise E. Barron, Seongsoo Lee, Jiwon Seo

JOURNAL OF PEPTIDE SCIENCE (2022)

Review Clinical Neurology

Targeting Impaired Antimicrobial Immunity in the Brain for the Treatment of Alzheimer's Disease

Tamas Fulop, Shreyansh Tripathi, Serafim Rodrigues, Mathieu Desroches, Ton Bunt, Arnold Eiser, Francois Bernier, Pascale B. Beauregard, Annelise E. Barron, Abdelouahed Khalil, Adam Plotka, Katsuiku Hirokawa, Anis Larbi, Christian Bocti, Benoit Laurent, Eric H. Frost, Jacek M. Witkowski

Summary: Alzheimer's disease is the most common form of dementia, with aging being the main risk factor. The exact cause of AD is unknown, but research suggests that chronic low-grade infection in the brain may play a role in the development of the disease. Inflammation may lead to neurodegeneration in AD.

NEUROPSYCHIATRIC DISEASE AND TREATMENT (2021)

No Data Available